Syra Health Posts Record $2.6 Million Revenue and 46.3% Gross Margin

What happened

Syra Health reported record third-quarter 2026 revenue of $2.6 million, up 52% from a year earlier, with a company-record 46.3% gross margin and net income of $344,610, marking its third consecutive profitable quarter.

Confirmed

Global impact / market context

A higher gross margin means Syra keeps more profit from each dollar of sales, which helped turn last year's loss into profit. The company also said it remains on track for full-year profitability in 2026, a goal that depends on carrying this performance through the fourth quarter.

Confirmed

Syra sells population health analytics and healthcare workforce staffing, areas tied to government-funded care programs. Revenue growth and record profitability may signal stronger demand and better pricing power, but investors should weigh whether gains from Medicaid-related work can continue.

Analyst inference

What to watch

1. Watch fourth-quarter revenue and gross margin to see whether the 46.3% margin holds, since the full-year profitability goal depends on repeating recent results. Confirmed
2. Track whether Syra's population health implementations and Medicaid managed care engagements convert into signed contracts or expanded work with existing customers. Proposed
3. Monitor expenses and cash needs as revenue grows, because staffing and technology costs could pressure profit per sale even if sales keep rising. Analyst inference

Evidence

• Original source link unavailable